The routine commissioning of brimonidine 0.5% gel (Mirvaso®) is not accepted in Devon for the symptomatic treatment of facial erythema of rosacea in adult patients.
| Filename: | Brimonidine for the symptomatic treatment of facial erythema of rosacea in adult patients |
| Filetype: | |
| Filesize: | 50.25 KB |
| Date uploaded: | 26th June 2015 |
| Date updated: | 8th December 2022 |
